Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study
Canadian Journal of Cardiology · 2026-09 · 42 (9) · 2240-2247
DOI: 10.1016/j.cjca.2026.04.034 ↗Kurz gefasst
Leitlinie in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Victoria Ivensky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Université de Montréal, Montreal, Quebec, Canada; Hôpital du Sacré-Coeur de Montréal, CIUSSS-du-Nord-de-l'île-de-Montréal, Mo…. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Practice Guidelines as Topic. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Health Canada, Institute of Circulatory and Respiratory Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Université de Montréal, Montreal, Quebec, Canada; Hôpital du Sacré-Coeur de Montréal, CIUSSS-du-Nord-de-l'île-de-Montréal, Montreal, Quebec, Canada.
- Department of Medicine, Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada; Inflammation and Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Department of Medicine, Division of Endocrinology and Metabolism, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, Cumming School of Medicine, Univers…
- EPICORE Centre, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Department of Medicine, Université de Montréal, Montreal, Quebec, Canada; Hôpital du Sacré-Coeur de Montréal, CIUSSS-du-Nord-de-l'île-de-Montréal, Montreal, Quebec, Canada; Department of Pharmacology and Physiology, Uni…
Förderung
- Canadian Institutes of Health Research
- Health Canada
- Institute of Circulatory and Respiratory Health
- Génome Québec
- Partenariat Canadien Contre Le Cancer
Zitieren
APA
Ivensky, V., Hundemer, G. L., Leung, A. A., Tsuyuki, R. T., & Goupil, R. (2026). Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study. Canadian Journal of Cardiology, 42(9), 2240-2247. https://doi.org/10.1016/j.cjca.2026.04.034
Vancouver
Ivensky V, Hundemer GL, Leung AA, Tsuyuki RT, Goupil R. Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study. Canadian Journal of Cardiology. 2026;42(9):2240-2247. doi:10.1016/j.cjca.2026.04.034
BibTeX
@article{Ivensky2026,
author = {Ivensky, Victoria and Hundemer, Gregory L and Leung, Alexander A and Tsuyuki, Ross T and Goupil, Rémi},
title = {Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {9},
pages = {2240--2247},
doi = {10.1016/j.cjca.2026.04.034}
}
EUVIMED